This HTML5 document contains 115 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1182/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q54625613
rdf:type
wikibase:Item
schema:description
2005年学术文章 tudományos cikk 2005年學術文章 artigo científico научни чланак artículo científico publicado en 2005 vitskapeleg artikkel wissenschaftlicher Artikel articol științific article scientifique (publié 2005) 2005年學術文章 wetenschappelijk artikel 2005年学术文章 scienca artikolo научна статия article scientific מאמר מדעי 2005年の論文 ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico (publicado na 2005) مقالهٔ علمی mokslinis straipsnis 2005年学术文章 article científic artigo científico (publicado na 2005) наукова стаття, опублікована в грудні 2005 videnskabelig artikel (udgivet 2005) scientific article bài báo khoa học мақолаи илмӣ سائنسی مضمون 2005년 논문 artikulong pang-agham bilimsel makale 2005 nî lūn-bûn 2005年學術文章 articolo scientifico naučni članak 2005年學術文章 գիտական հոդված სამეცნიერო სტატია tieteellinen artikkeli мақолаи илмӣ บทความทางวิทยาศาสตร์ 2005年學術文章 vědecký článek مقالة علمية vitenskapelig artikkel επιστημονικό άρθρο 2005年学术文章 научная статья 2005年學術文章 artykuł naukowy 2005年学术文章 artikull shkencor teaduslik artikkel научни чланак artículu científicu vedecký článok vetenskaplig artikel
p:P577
wds:Q54625613-7DD25B48-DFD8-40AD-A555-38A499CF0884
wdt:P577
2005-12-22T00:00:00Z
p:P407
wds:Q54625613-BA9A107F-3D55-465B-BA6A-416A2326A269
wdt:P407
wd:Q1860
p:P2093
wds:Q54625613-6C2FB2D6-0EC4-400E-86E0-19A9B979ABC8 wds:Q54625613-57F8ABC8-9E42-424F-9B6B-AD1145A23ECC wds:Q54625613-0B0026A7-F826-4A43-B653-413ABB5466AE
wdt:P2093
Laura Vanelli Matteo G Della Porta Mario Cazzola
rdfs:label
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders. Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.
skos:prefLabel
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders. Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.
schema:name
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders. Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.
p:P50
wds:Q54625613-66F07280-8B6C-4364-BC33-082C71C4B16B wds:Q54625613-7A72CDFF-C7EC-4143-92C5-CFF423FE7E1D wds:Q54625613-8845ADAA-C74C-4063-B3D3-7A79EEEE949D wds:Q54625613-9AF6398D-1C16-4601-B031-D5C1DC9B615F wds:Q54625613-D9883914-CADE-4920-A2B6-E672DF548EE9 wds:Q54625613-1AFB6DBF-C399-4A25-8E89-1DAD7DF0F2F3 wds:Q54625613-2362ECC6-73FC-41C9-88AE-87012BF0FB19 wds:Q54625613-44C45E9F-897E-4AAF-B16C-2ABB4C9FF731 wds:Q54625613-609520F0-ECF7-4E71-A7C5-4E5DF6A11E12
wdt:P50
wd:Q117240788 wd:Q89931599 wd:Q85642951 wd:Q43138347 wd:Q42033215 wd:Q42389421 wd:Q117240779 wd:Q117240780 wd:Q88970015
p:P1476
wds:Q54625613-DD4E8B34-77A0-4CB8-B23A-B0F10DB8C958
wdt:P1476
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.
p:P304
wds:Q54625613-CA69CFDD-5D65-41C4-9462-93CC0F67ECFF
wdt:P304
3676-3682
p:P31
wds:Q54625613-1BF09C88-B0FE-4645-A1A3-C632414E6536
wdt:P31
wd:Q13442814
p:P698
wds:Q54625613-686B93B6-6776-440F-AE03-E4111F9942E9
wdtn:P698
n10:16373657
wdt:P698
16373657
p:P1433
wds:Q54625613-35BA27AB-B02E-4823-85A5-05FF8D87D15F
wdt:P1433
wd:Q885070
p:P433
wds:Q54625613-3B7CD9D1-4BDF-4BD3-B321-D9D7F04CBAE2
p:P478
wds:Q54625613-A0C0C2C7-DABF-4F0F-9F2F-71FF02D83CDB
wdt:P433
9
wdt:P478
107
p:P356
wds:Q54625613-58629FA6-C7E0-4BD2-B848-8413C386B8F8
wdtn:P356
n12:BLOOD-2005-09-3826
wdt:P356
10.1182/BLOOD-2005-09-3826
p:P5875
wds:Q54625613-05D68027-90F8-4740-B007-1EE6637C67BB
wdt:P5875
7396915